Brandywine Global Investment Management LLC Boosts Stock Holdings in Kenvue Inc. $KVUE

Key Points

• Brandywine Global Investment Management LLC significantly increased its stake in Kenvue Inc. by 958.6%, acquiring 841,118 shares during the first quarter, bringing its total holdings to 928,861 shares valued at $22.27 million.
• Kenvue has announced a quarterly dividend increase to $0.2075, up from $0.21, with an annualized yield of 3.9% and an ex-dividend date set for August 13th.
• The company reported a net revenue decline of 4.0% year-over-year for the recent quarter, with earnings per share surpassing analysts' expectations at $0.29, though it still fell short of revenue estimates at $3.84 billion.

Brandywine Global Investment Management LLC raised its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 958.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 928,861 shares of the company's stock after purchasing an additional 841,118 shares during the quarter. Brandywine Global Investment Management LLC's holdings in Kenvue were worth $22,274,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Price T Rowe Associates Inc. MD grew its position in shares of Kenvue by 3.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company's stock worth $5,249,665,000 after buying an additional 8,211,748 shares during the last quarter. Vanguard Group Inc. raised its stake in Kenvue by 4.9% during the first quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company's stock valued at $5,494,882,000 after buying an additional 10,600,682 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Kenvue by 2.5% during the first quarter. Charles Schwab Investment Management Inc. now owns 25,606,238 shares of the company's stock valued at $613,882,000 after buying an additional 633,461 shares during the last quarter. Boston Partners raised its stake in shares of Kenvue by 7.4% in the first quarter. Boston Partners now owns 25,346,453 shares of the company's stock worth $606,920,000 after purchasing an additional 1,750,490 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Kenvue by 11.6% in the first quarter. JPMorgan Chase & Co. now owns 24,912,226 shares of the company's stock worth $597,395,000 after purchasing an additional 2,597,920 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Kenvue Stock Up 1.8%

Shares of Kenvue stock traded up $0.3850 during trading on Tuesday, reaching $21.4850. The company's stock had a trading volume of 13,900,327 shares, compared to its average volume of 17,538,854. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The company has a market cap of $41.23 billion, a price-to-earnings ratio of 29.03, a P/E/G ratio of 3.05 and a beta of 0.83. Kenvue Inc. has a 1-year low of $19.75 and a 1-year high of $25.17. The company has a 50-day simple moving average of $21.54 and a two-hundred day simple moving average of $22.42.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. The firm had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The business's quarterly revenue was down 4.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th will be given a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $0.83 dividend on an annualized basis and a yield of 3.9%. This is an increase from Kenvue's previous quarterly dividend of $0.21. Kenvue's payout ratio is presently 112.16%.

Analyst Ratings Changes

KVUE has been the subject of several research analyst reports. Canaccord Genuity Group cut their price objective on Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a report on Friday, August 8th. UBS Group reduced their price target on Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Royal Bank Of Canada dropped their price objective on Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a research note on Friday, August 8th. JPMorgan Chase & Co. dropped their price target on Kenvue from $27.00 to $26.00 and set an "overweight" rating for the company in a research note on Friday, July 25th. Finally, Zacks Research raised Kenvue to a "strong sell" rating in a research note on Monday, August 11th. Five research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $24.38.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.